Introduction {#s1}
============

The NCI-60 [@pone.0040062-Weinstein1] is a panel of 60 human cancer cell lines used by the Developmental Therapeutics Program (DTP) of the U.S. National Cancer Institute to screen \>100,000 compounds plus natural products since 1990. The NCI-60 panel includes cancers of colorectal (CO), renal (RE), ovarian (OV), prostate (PR), lung (LC), breast (BR), and central nervous system (CNS) origin, as well as leukemias (LE) and melanomas (ME). We and our many colleagues around the world have profiled the NCI-60 more comprehensively at the DNA, RNA, protein, mutation, functional, and pharmacological levels than any other panel of diverse cell types in existence. The NCI-60 data have been widely used in cancer research and bioinformatics, but the multiple datasets may be most informative for the recognition of complex 'biosignatures' (a 'biosignature' involves an ensemble of genes whose features are predictive). Analysis of such biosignatures has led to increased understanding of cell phenotypes and pathway relationships.

When we recently clustered genes based on correlation of expression profiles across the NCI-60 [@pone.0040062-Zeeberg1], many of the clusters were associated with cancer-related biological functions. The number of such clusters far exceeded what would be expected by chance. One of the clusters, designated as "cluster 52 of the 160-cut," was comprised of significant categories that generally reflected neuron development, immune response, and epithelial to mesenchymal transition (EMT) in addition to cell migration. In contrast, cluster 68 of the 160-cut was focused strongly on a single biological process, namely immune function.

![Thumbnails of gene correlation clustering for Cluster 52 genes across (A) NCI-60 cell lines and (B) TCGA GBM samples.\
The full size figures are available as Figures S1 and S2. The numbers appended after the gene name refer to the NCI-60 cluster in which that gene appeared.](pone.0040062.g001){#pone-0040062-g001}

A previous study [@pone.0040062-Ross1] compared the gene expression profiles between cell lines and breast tumor tissue samples. The authors noted that: "cell lines and tumors share many aspects of their gene expression patterns that can be related to the normal and pathological physiology that distinguishes breast cell types *in vivo*. These gene sets include 1) the basal epithelial cluster, 2) the luminal epithelial/ER+ cluster, 3) the ERBB2+ amplicon cluster, 4) the proliferation cluster, and 5) the interferon cluster."

10.1371/journal.pone.0040062.t001

###### Contingency table for cluster 52 re-clustered across NCI-60 and across GBM.

![](pone.0040062.t001){#pone-0040062-t001-1}

                        GBM CLUSTER   MARGINALS            
  -------------------- ------------- ----------- ---- ---- ----
  **NCI-60 CLUSTER**       **1**          9       1    5    15
                           **2**         12       34   18   64
  **MARGINALS**             21           35       23   79  

The Fisher Exact p-value corresponding to this contingency table was 0.00039.

Cancer cells in culture are subject to very different conditions than tumor cells in the host. They have been removed from their physiological milieu of other cell types, tissue architecture, hormonal influences, and autocrine/paracrine signals. So the question remained: "What does such a pattern of association in cell culture tell us about cancer cells in vivo?".

To explore that question, we analyzed the highly curated glioblastoma (GBM) transcript expression data set generated by the The Cancer Genome Atlas (TCGA) initiative [@pone.0040062-CancerGenomeAtlasResearch1]. TCGA was established to build a comprehensive catalogue of genomic and phenotypic abnormalities that drive carcinogenesis and potentially affect therapy in \>20 different tumor types. In particular, TCGA has now provided a detailed view of genomic aberrations in a GBM cohort consisting of 206 patient samples. Verhaak and Hoadley *et al.* [@pone.0040062-Verhaak1] recently described a gene expression-based molecular classification of GBM into Proneural, Neural, Classical and Mesenchymal subtypes and integrated multiple types of genomic data to establish patterns of somatic mutation, DNA copy number change, and gene expression.

10.1371/journal.pone.0040062.t002

###### Fisher Exact p-values for concordance of re-clustering cluster 52 across NCI-60 and across GBM.
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  NUMBER OF CLUSTERS (parameter "k" of cutree())                                                         
  ------------------------------------------------ ------------- --------- --------- --------- --------- ---------
  0.00254                                           **0.00039**   0.00103   0.00093   0.00167   0.00157   0.00189

The Fisher's Exact p-value for 100 randomizations corresponding to k = 3 was 0.464±0.279. The bold value indicates the lowest p-value model for the reals. This was the model used for the remainder of the cluster 52 analysis.

10.1371/journal.pone.0040062.t003

###### Concordance of cluster 52 genes in NCI-60 and GBM clusters.
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                        GBM CLUSTER                       
  -------------------- ------------- -------- ----------- ---------
  **NCI-60 CLUSTER**       **1**      ACCN2       FOS       GALK2
                                      ALDOC                 MCAT
                                      EPB41                MRPS30
                                      FOXO4                 SCO2
                                      MUTYH                SLC43A1
                                       OXSM               
                                      PDE3B               
                                      PRMT7               
                                       SORD               
                           **2**       AGER      ACTB       ACTN3
                                      ALCAM      ADAM9      CDH2
                                       DBN1       AXL       CDH4
                                      DDAH1      CAV1       CHST3
                                      DYNLL1     CAV2       DKK3
                                       GLRB      CLIC4      EGFR
                                      MYBL1      CNN2       FADS3
                                       NMT2      DLC1       FEZ2
                                      ROBO3       DSE       FGF2
                                      SYNE1      DUSP1     KCNMA1
                                      TRPC1      FGFR1      MGLL
                                      ZNF281     FOSL2      MT1X
                                                GADD45A     MYL6
                                                 GAS6       SOCS5
                                                  IL6      SORBS3
                                                 INHBA      TGFB2
                                                 ITGB1      TUFT1
                                                  JUN       VCAN
                                                 KLF7     
                                                 LOXL2    
                                                 MYH9     
                                                 MYLK     
                                                 PDGFC    
                                                PDLIM7    
                                                 PTRF     
                                                  PVR     
                                                 QSOX1    
                                                 RRAS     
                                                TGFB1I1   
                                                 THBS1    
                                               TNFRSF12A  
                                                 TRAM1    
                                                  VCL     
                                                  ZYX     

In the present analysis, we tested whether sets of genes that we previously found to be (1) highly co-expressed across the NCI-60, and (2) functionally coherent were also highly co-expressed across the GBM samples. We then extended that basic analysis by a "double fishing" strategy. That is, we identified sets of genes that showed correlation ≥0.60 in both the NCI-60 and GBM data sets relative to a given "bait" gene. We found that the number of such gene sets far exceeded the number expected by chance. That analysis does not mean that cancer cells in culture share all, or even most, of their characteristics with cells in vivo, but it does indicate similarities.

10.1371/journal.pone.0040062.t004

###### Contingency table for cluster 68 re-clustered across NCI-60 and across GBM.

![](pone.0040062.t004){#pone-0040062-t004-4}

                        GBM CLUSTER   MARGINALS                 
  -------------------- ------------- ----------- ---- ---- ---- ----
  **NCI-60 CLUSTER**       **1**          8       11   0    5    24
                           **2**         11       12   38   14   75
  **MARGINALS**             19           23       38   19   99  

The Fisher Exact p-value corresponding to this contingency table was 0.00001.

10.1371/journal.pone.0040062.t005

###### Fisher Exact p-values for concordance of re-clustering cluster 68 across NCI-60 and across GBM.

![](pone.0040062.t005){#pone-0040062-t005-5}

  NUMBER OF CLUSTERS (parameter "k" of *cutree()*)                                                         
  -------------------------------------------------- --------- ------------- --------- --------- --------- ---------
  0.09162                                             0.10917   **0.00001**   0.00001   0.00001   0.00001   0.00001

The Fisher's Exact p-value for 100 randomizations corresponding to k = 3 was 0.529±0.283. The bold value indicates the lowest p-value model for the reals. This was the model used for the remainder of the cluster 68 analysis.

Methods {#s2}
=======

Datasets {#s2a}
--------

For GBM expression data, the files *unifiedScaled.txt* (which contains a complete set of expression data, referred to as *TCGA.GBM.complete*) *TCGA_unified_CORE_ClaNC840.txt* (which includes the subtype tags of each sample) were downloaded from the TCGA web site <http://tcga-data.nci.nih.gov/docs/publications/gbm_exp/>.

10.1371/journal.pone.0040062.t006

###### Concordance of cluster 68 genes in NCI-60 and GBM clusters.
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                        GBM CLUSTER                                
  -------------------- ------------- --------- --------- --------- ---------
  **NCI-60 CLUSTER**       **1**      ACVR2A    ADAM15                APP
                                      CSNK1G3   AGPAT3               DOCK1
                                       CTBP2     AHNAK               MLF1
                                      MAP3K13    DUSP3               NOL3
                                       SMAD5     EMP2                 OAT
                                       YES1       GRN              
                                      ZNF205     LMNA              
                                       ZNF35    MGAT4B             
                                                 PLP2              
                                                  SPR              
                                                 ZFHX3             
                           **2**      CHRNA3      ADA      AIF1       C9
                                      CYFIP2    ALDH1A2   ARHGDIB    CD1A
                                      ELOVL4     CD1E      CCR4      GDF10
                                       GNB1L     CD79A     CCR7      GRAP
                                       GRIK5      GP5      CD1D      LY6H
                                        MYB      IGLL1     CD27     NKX2-5
                                      NFKBIL1    KRT1      CD3D      PRKCQ
                                       SLIT1     LAX1      CD3E      RAG2
                                       SMPD3      LTA      CD3G     RASGRP2
                                      TSPAN7     PTGDR      CD4      RORB
                                       USP20     RAG1       CD5     SLC15A2
                                                 SEPT6     CD52     SLC18A2
                                                            CD7      TAL1
                                                           CD84     VPREB1
                                                           CD96    
                                                           CECR1   
                                                           CTSW    
                                                           FLI1    
                                                            FYB    
                                                           GFI1    
                                                           GMFG    
                                                           GNA15   
                                                           GRAP2   
                                                          IL12RB1  
                                                           IL2RG   
                                                           ITGAL   
                                                           ITGB2   
                                                            ITK    
                                                           LST1    
                                                          MAP4K1   
                                                           RHOH    
                                                           SELL    
                                                          SH2D1A   
                                                           SIT1    
                                                            SPN    
                                                           TRAT1   
                                                          TREML2   
                                                           ZAP70   

We used all 202 GBM samples that are available, representing roughly comparable numbers of samples of each subtype. Since the calculated correlation values will be more accurate if they come from a more diverse sampling population, we wanted to retain as much diversity as possible by looking at all subtypes together, so we did not report co-expression within or between subtypes.

![Thumbnails of gene correlation clustering for Cluster 68 genes across (A) the NCI-60 cell lines and GBM samples (B).\
The full size figures are available as Figures S3 and S4. The numbers appended after the gene name refer to the NCI-60 cluster in which that gene appeared.](pone.0040062.g002){#pone-0040062-g002}

![Thumbnail of GO category *versus* gene list CIM for sets of genes with correlation ≥0.60 across both the NCI-60 and GBM samples.\
The full size CIM is available as Figure S5. The gene name given as the column header is the representative of a list of genes. The full list of genes is available in the HTGM Download S1.](pone.0040062.g003){#pone-0040062-g003}

NCI-60 expression data were obtained from CellMiner [@pone.0040062-Shankavaram1]. Determination of composite expression levels for each gene was performed as described previously [@pone.0040062-Gmeiner1]--[@pone.0040062-Reinhold1]. A special request was made to the system administrator for the complete set of gene expression profiles (referred to as *NCI-60.complete*). That download would have been too large to perform through the standard web interface. Further details are provided in [@pone.0040062-Zeeberg1]). Briefly, *NCI-60.complete* was pre-processed by selecting only those genes that have both an HGNC symbol and annotation in the GO Biological Process ontology. Each gene profile vector was scaled to zero mean and unit variance. That reduced dataset is referred to here as *NCI-60.BP.*

As mentioned above for the GBM samples, we are trying to achieve as high a degree of diversity as possible in the cell lines, so that the highly heterogeneous mixture of cell lines represented by the NCI-60 is ideal. For illustration, consider two genes. We are looking to see if the expression levels of those two genes go up and down together as we traverse the 60 cell lines. If all of the cells lines were essentially identical to one another, there would be no variation and we could not see how the two genes relate in different conditions.

For most of the studies reported here, the expression data for GBM and for NCI-60 were restricted to those genes that were present in both *TCGA.GBM.complete* and *NCI-60.BP*.

10.1371/journal.pone.0040062.t007

###### Summary of high ranking genes with correlation ≥0.60 across both NCI-60 and GBM.

![](pone.0040062.t007){#pone-0040062-t007-7}

  rank    Designated gene (G)   number of genes with correlation ≥0.60   generalized functional correlation   number of genes incommon with cluster 52   Number of genes in common with cluster 68
  ------ --------------------- ---------------------------------------- ------------------------------------ ------------------------------------------ -------------------------------------------
  1               WAS                             50                                   immune                                    0                                          21
  2              IL2RG                            37                                   immune                                    0                                          23
  3               CD4                             37                                   immune                                    0                                           9
  4              CD48                             36                                   immune                                    0                                          13
  5              PTPRC                            35                                   immune                                    0                                          15
  6              PTPN7                            35                                   immune                                    0                                          12
  7              HCLS1                            35                                   immune                                    0                                          12
  8             CORO1A                            35                                   immune                                    0                                          11
  9              CD37                             34                                   immune                                    0                                           8
  10             PLCB2                            33                                   immune                                    0                                          12
  11             RHOH                             32                                   immune                                    0                                          16
  12            LILRA2                            31                                   immune                                    0                                           4
  13             LRMP                             29                                   immune                                    0                                           9
  14            RNASE6                            28                                   immune                                    0                                           3
  15             NCF4                             28                                   immune                                    0                                           0
  16             CD3D                             28                                   immune                                    0                                          20
  17             CSF3R                            27                                   immune                                    0                                           4
  18             CYBB                             26                                   immune                                    0                                           0
  19             SIT1                             23                                   immune                                    0                                          19
  20             DOCK2                            23                                   immune                                    0                                           9
  21             CD1D                             23                                   immune                                    0                                          14
  22             MYH9                             21                                angiogenesis                                 7                                           0
  23              CD2                             21                                   immune                                    0                                          15
  24           SERPINE1                           20                                angiogenesis                                 4                                           0
  25             LOXL2                            20                                angiogenesis                                 4                                           0
  26             CYR61                            20                                angiogenesis                                 6                                           0
  27            SH2D1A                            19                                   immune                                    0                                          14
  28             GNA15                            19                                   immune                                    0                                          10
  29            COL5A1                            19                            extracellular matrix                             2                                           0
  30              BTK                             19                                   immune                                    0                                           2
  31             LY86                             18                                   immune                                    0                                           0
  32              LOX                             18                                angiogenesis                                 2                                           0
  33             FLNA                             18                             cell-cell junciton                              6                                           0
  34             CD52                             18                                   immune                                    0                                          13
  35            S100A8                            17                                   immune                                    0                                           2
  36            RNASE3                            17                                   immune                                    0                                           2
  37            LGALS9                            17                                   immune                                    0                                           8
  38            CSF2RB                            17                                   immune                                    0                                           0
  39              CD5                             17                                   immune                                    0                                          13
  40           TNFRSF12A                          16                                 chemotaxis                                  5                                           0
  41            ST8SIA4                           16                          tyrosine phosphorylation                           0                                           5
  42             PLK4                             16                                  mitosis                                    0                                           0
  43             OAS2                             16                                   immune                                    0                                           0
  44             MCM3                             16                                 DNA repair                                  0                                           0
  45             LSP1                             16                                   immune                                    0                                           2
  46             ITGB2                            16                                   immune                                    0                                          10
  47             CD96                             16                                   immune                                    0                                          14
  48              CD7                             16                                   immune                                    0                                          11
  49            ATP2A3                            16                                   immune                                    0                                          12
  50            COL1A2                            15                            extracellular matrix                             0                                           0
  51             CCR7                             15                                   immune                                    0                                          13
  52            ADAM12                            15                            extracellular matrix                             1                                           0
  53             MED6                             14                                     NA                                      0                                           0
  54            LGALS1                            14                                     NA                                      0                                           0
  55              LCK                             14                                   immune                                    0                                          10
  56             FOSL2                            14                                angiogenesis                                 4                                           0
  57              DSE                             14                                   immune                                    4                                           0
  58            COL6A3                            14                            extracellular matrix                             0                                           0
  59            COL1A1                            14                            extracellular matrix                             1                                           0
  60             CLCF1                            14                          tyrosine phosphorylation                           7                                           0
  61             ANXA2                            14                                     NA                                      3                                           0
  62            PTPN22                            13                                     NA                                      0                                           4
  63             PLAUR                            13                                   immune                                    1                                           0
  64              LTB                             13                                   immune                                    0                                          11
  65             CTSW                             13                                   immune                                    0                                          13
  66             IRAK3                            12                                   immune                                    0                                           0
  67             GRB7                             12                                     NA                                      0                                           0
  68             CTCF                             12                             chromatin assembly                              0                                           0

The designated gene (G) appearing in the gene column is the representative of a group of genes that correlate strongly with G.

"NA" indicates that the gene set did not map to any statistically significant GO categories.

The complete High-Throughput GoMiner (HTGM) download is provided in file Download S1. The files in the subdirectory work2026406846/inputFileDir are named according to each gene G. Each such file contains the complete list of genes correlating with G.

R Language {#s2b}
----------

R language code [@pone.0040062-R1] was developed to read and integrate the data in the two downloaded files, as well as to provide support for both basic and more complex queries \[*e.g.*, automatically find sets of genes meeting certain conditions with respect to both NCI-60 and GBM and then generate a relevant series of expression or correlation clustered image maps (CIMs)\]. Historically, CIMs were first introduced in [@pone.0040062-Weinstein2], [@pone.0040062-Weinstein3].

Studies Predicated on Pre-existing Correlations Across the NCI-60 {#s2c}
-----------------------------------------------------------------

The key question we addressed here was whether genes that co-clustered with respect to their expression profiles across the NCI-60 cells also co-clustered with respect to their expression profiles across the GBM samples. To facilitate that analysis, we took advantage of the R language function *cutree()*. A key parameter in *cutree()* is "k" the number of clusters into which the cluster tree is to be divided. In the cluster 52 and cluster 68 studies (*i.e.,* sets of genes reported in [@pone.0040062-Zeeberg1]), preliminary studies showed that k = 2 was optimal for NCI-60 expression clusters. Each such gene set had been derived from a clustering study using an absolute correlation metric, and therefore had two major partitionings (*e.g.*, [Figures 1A, S](#pone-0040062-g001){ref-type="fig"}1). The two partitionings are designated as "cluster 1" and "cluster 2," and are delineated by the number appended to each gene name on the right of the CIM. The genes within a single partitioning are mutually positively-correlated, and all genes in cluster 1 are negatively-correlated with all genes in cluster 2. We colloquially refer to the larger cluster (in the case of [Figures 1A, S](#pone-0040062-g001){ref-type="fig"}1, this would be cluster 2) as the "positively-correlated" genes and the smaller cluster as the "negatively-correlated" genes. In contrast to k = 2 for NCI-60, there was no *a priori* basis for selecting a particular value of k for the clustering across GBM, so we allowed k for GBM to range from 2 through 8.

To determine the optimal value of k, we constructed a 2×k contingency table (*e.g.,* [Table 1](#pone-0040062-t001){ref-type="table"}), each cell~i,j~ of which contains the number of genes that are both in the i^th^ cluster of the NCI-60 clustering and the j^th^ cluster of the GBM clustering. We computed a Fisher's exact p-value for the null hypothesis that a distribution as extreme as the observed distribution could have occurred by chance. In addition, we randomized the gene names between performing the NCI-60 and GBM clusterings, to determine if the observed Fisher's exact p-value could be achieved for a random gene set.

De novo Identification of Sets of Genes with Correlation ≥0.60 Across both NCI-60 and GBM {#s2d}
-----------------------------------------------------------------------------------------

Without reference to any prior clustering analysis, the program constructed *de novo* a list of all pairs of genes having correlation ≥0.60 with respect to both NCI-60 and GBM expression profiles. The threshold of 0.60 was chosen for the calculations because it had been used in an earlier study of gene-gene correlations to minimize the number of false positives. Genes were ranked with respect to frequency of appearance in that list. Each gene "G" with frequency ≥5 was then used to "represent" the set of genes that showed correlation ≥0.60 with G. The top-ranking G gene was WAS (49 genes had correlation ≥0.60 with WAS). Many of the gene lists constructed by that method were highly redundant with respect to one another (*i.e.*, pairs of lists may have many gene in common). To alleviate the redundancy problem, we computed the Jaccard similarity metric (the Jaccard coefficient measures similarity between sample sets, and is defined as the size of the intersection divided by the size of the union of the sample sets [@pone.0040062-Jaccard1]) we eliminated highly redundant (Jaccard value ≥0.90; 0.90 was determined to be optimal in preliminary studies not shown here) gene sets from further analysis. Thus, we used a less-redundant set of 68 gene sets (from an initial selection of the top (possibly redundant) 100 gene sets) for the analysis.

We wished to determine if the number of pairs of genes having correlation ≥0.60 with respect to both NCI-60 and GBM expression profiles exceeded the number expected by chance. We therefore performed a set of 10 studies in which we randomized the gene names in the GBM expression profiles. The number of such pairs obtained in the real study was 2708. In contrast, the number in the randomization studies was small in comparison (193±14).

Functional Categorization {#s2e}
-------------------------

Functional categorization of gene lists was performed using the High-Throughput GoMiner (HTGM) program [@pone.0040062-Zeeberg2]. The parameters used in running HTGM are tabulated in [Table S1](#pone.0040062.s006){ref-type="supplementary-material"}.

Clustered Image Maps {#s2f}
--------------------

We used either the Genesis clustering program [@pone.0040062-Sturn1] or our own in-house R language code to construct CIMs presented here.

Results and Discussion {#s3}
======================

Studies Predicated on Existing Correlations Across the NCI-60 {#s3a}
-------------------------------------------------------------

We recently clustered genes based on correlation of expression profiles across the NCI-60 [@pone.0040062-Zeeberg1]. Many of those clusters were characterized by cancer-associated biological functions.

Using the expression profiles for the cluster 52 genes across the NCI-60 cell lines and also across the GBM samples, we were able to generate expression correlation CIMs across both of those sets of expression profiles ([Figures 1A, S](#pone-0040062-g001){ref-type="fig"}1, 1B, S2). The distinct patterns of red and green in the NCI-60 correlation CIM ([Figures 1A, S](#pone-0040062-g001){ref-type="fig"}1) results from the fact that cluster 52 had been derived by clustering the expression profiles in the NCI-60 cell lines using an absolute correlation metric. Thus, cluster 52 is composed of "negatively" and "positively" correlated subgroups. Not surprisingly, the patterns of red and green are less distinct in the GBM correlation CIM ([Figures 1B, S](#pone-0040062-g001){ref-type="fig"}2), since cluster 52 had been defined relative to NCI-60, not GBM, expression patterns. Although less distinct than for NCI-60, the GBM pattern is highly correlated with the pattern for NCI-60. That relationship is obvious by visual inspection. The quantitative analysis below confirms the visual impression.

In the correlation CIMs, we appended a number (1 or 2) to the gene names, corresponding to membership in the two major clusters in the NCI-60 CIM. Those same numbers were retained in the gene names for the GBM CIM to allow identification of the cluster to which that gene belonged in the NCI-60 CIM. The pattern of clustering in the GBM correlation CIM ([Figures 1B, S](#pone-0040062-g001){ref-type="fig"}2) is markedly similar to that in the NCI-60 CIM. That observation shows that some gene co-expression patterns in the NCI-60 human tumor cell line panel are preserved in clinical glioblastoma, and supports our conjecture that NCI-60 gene expression correlations can indicate widely applicable gene-gene relationships.

More precisely, [Table 1](#pone-0040062-t001){ref-type="table"} shows that there are 15 genes in cluster 1 and 64 genes in cluster 2, relative to the NCI-60 expression profile. Thirty-four of the 64 cluster 2 genes are the predominant members of GBM cluster 2. The remaining NCI-60 cluster 2 genes are distributed across GBM clusters 1 and 3. The concordance between the clustering patterns in NCI-60 and GBM is highly significant ([Table 2](#pone-0040062-t002){ref-type="table"}). The Fisher's exact p-value for k = 3 (0.00039) is strikingly lower than for the randomized controls (0.46±0.28). Furthermore, the large majority of the genes that were mutually correlated or anti-correlated in the NCI-60 preserved that relationship in the GBM tissue samples. The identities of the relevant genes are shown in [Table 3](#pone-0040062-t003){ref-type="table"}.

A notable finding is that nearly half of the genes in GBM cluster 2 ([Figures 1B, S](#pone-0040062-g001){ref-type="fig"}2) are genes that were previously found to be involved in cell adhesion/migration and to form a mutually-high correlation subset of the cluster 52 genes [@pone.0040062-Kohn1]. Moreover, those genes were found to function coherently in a particular aspect of the cell migration process. With the exception of ALCAM and EGFR, the cell adhesion/migration tight cluster genes fall within GBM cluster 2. Sixteen of twenty-four genes of that tight cluster fall into GBM cluster 2. Thus, a set of genes previously found to be closely related in both gene expression and function in the NCI-60 cell lines [@pone.0040062-Zeeberg1], [@pone.0040062-Kohn1] are now found to be co-expressed also in clinical glioblastoma samples.

To investigate other potential examples of coherence between gene expression clusters in NCI-60 cell lines and GBM samples, we repeated that analysis with the immune system-related cluster 68 genes [@pone.0040062-Zeeberg1] ([Tables 4](#pone-0040062-t004){ref-type="table"}--[6](#pone-0040062-t006){ref-type="table"}; [Figures 2A, S](#pone-0040062-g002){ref-type="fig"}3, 2B, S4). Again, the Fisher's exact p-value (0.00001) ([Table 5](#pone-0040062-t005){ref-type="table"}) validates the visual impression that there is a significant concordance between the NCI-60 and the GBM clustering.

De novo Identification of Sets of Genes with Correlation ≥0.60 Across both NCI-60 and TCGA GBM {#s3b}
----------------------------------------------------------------------------------------------

There were 34,865 gene pairs with correlation ≥0.60 in the NCI-60 data set but not in GBM, 87,556 in GBM but not in the NCI-60, and 2,708 in both the NCI-60 and GBM. The highest-ranking gene of the 2,708 was WAS; 49 genes showed correlation ≥0.60 with WAS. Of the top 100 genes (*i.e.*, genes with the highest number of correlations ≥0.60), 68 were non-redundant (*i.e.*, the lists of correlating genes had Jaccard value ≤0.90). Functional categorization of those 68 gene lists by High-Throughput GoMiner (HTGM) revealed a complex set of significant categories ([Figures 3](#pone-0040062-g003){ref-type="fig"}, [S5](#pone.0040062.s005){ref-type="supplementary-material"}). The number of genes and the generalized functional correlations for the top 68 non-redundant gene sets are listed in [Table 7](#pone-0040062-t007){ref-type="table"}. As is evident from [Table 7](#pone-0040062-t007){ref-type="table"}, immune categories dominated, but [Table 7](#pone-0040062-t007){ref-type="table"} and [Figure S5](#pone.0040062.s005){ref-type="supplementary-material"} reveal that there were also categories representing *e.g.* apoptosis, chemotaxis, DNA repair, chromatin assembly, angiogenesis, and adhesion.

The genes in cluster 52 or cluster 68 had been obtained by prior clustering of the gene expression profiles across NCI-60 cell lines, but not across TCGA GBM samples. We expect to find that some of the *do novo* gene lists derived from simultaneous consideration of both NCI-60 cell lines and TCGA GBM samples might overlap with genes in the cluster 52 or cluster 68 gene lists. In fact, [Table 7](#pone-0040062-t007){ref-type="table"} shows that the genes in certain of the *de novo* gene lists overlapped with the genes in NCI-60 clusters 52 (cell migration) and 68 (immune). Such overlap is particularly strong for cluster 68.

This analysis shows ways in which strong gene-gene correlations and functional categorization (*ie.,* GO assignments) obtained for the NCI-60 cell lines across tumor types can reflect *in vivo* relationships. It also shows the limitations of such similarity. The two types of sample sets represent major initiatives of the National Cancer Institute (NCI), in terms of both expense and research investment. Hence, a delineation of the similarities and differences remains a subject of considerable practical importance.
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